Not Yet RecruitingNot Applicable

Comparative Effects of Elliptical Exercises and Swiss Ball Aerobics Exercises in Post CABG Patients

Pakistan32 participantsStarted 2026-05-10

Plain-language summary

This randomized controlled trial will compare the effectiveness of elliptical exercise training and Swiss ball exercise therapy in post-CABG patients. A total of 32 participants will be recruited through convenient sampling and randomly allocated into two groups (16 each). Group A will receive supervised elliptical exercise training, while Group B will perform Swiss ball exercises, with sessions conducted three times per week for 6-8 weeks. Outcomes including functional exercise capacity (Six-Minute Walk Test), resting heart rate (pulse oximetry), dyspnea (Modified Borg Scale), and quality of life (SF-36) will be assessed at baseline and post-intervention. Data will be analyzed using SPSS to determine the more effective rehabilitation approach for improving recovery after CABG.

Who can participate

Age range

40 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

INCLUSION CRITERIA * Adult patients aged 40 to 60 years who have undergone elective or scheduled coronary artery bypass grafting (CABG) surgery. * Post-operative duration between 2 to 6 weeks, medically cleared to begin rehabilitation exercises. * Hemodynamically stable (normal vital signs, no signs of acute cardiac distress). * Willing and able to participate in a supervised rehabilitation program. EXCLUSION CRITERIA * Patients with unstable angina, recent myocardial infarction (\<2 weeks), or uncontrolled arrhythmias. * Patients with severe valvular heart disease or left ventricular ejection fraction \<30%. * Individuals with neurological conditions (e.g., Parkinson's disease, stroke) that impair mobility or coordination. * Patients with severe musculoskeletal disorders (e.g., joint replacement, severe arthritis, recent fractures). * Cognitive impairment (e.g., dementia, significant memory loss) that prevents understanding or following instructions.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

functional capacity

Timeframe: pretreatment, 4th week, 8th week

Heart rate

Timeframe: pretreatment, 4th week, 8th week.

Dyspnoea

Timeframe: pretreatment, 4th week, 8th week

Quality of life in post-CABG patients

Timeframe: pretreatment, 4th week , 8th week

Trial details

NCT IDNCT07578805

SponsorRiphah International University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08-20

Contact for this trial

Imran Amjad, Phd

03324390125 imran.amjad@riphah.edu.pk

View on ClinicalTrials.gov More CABG trials